Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02807454
Brief Title: A Study to Determine the Safety and Efficacy for the Combination of Durvalumab and Daratumumab in Relapsed and Refractory Multiple Myeloma (FUSIONMM-003)

First Submitted : June 17, 2016
First Submitted that Met QC Criteria : June 17, 2016
First Posted : June 21, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : January 29, 2020
Last Update Posted : January 31, 2020